Pricing Log in Create free account
Saturday 17 October 2026 Export A’s income statement to Excel — free account

Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Agilent Technologies, Inc. (A) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Agilent Technologies, Inc. (A) trades at a P/S ratio of 6.6×. Over the past ten years it has ranged from 2.3× (September 2015) to 8.8× (September 2021); the current reading is higher than 88% of that period. That is above the Diagnostics & Research industry median of 4.4× and above the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 6.0× 3.06%
FY2024 5.8× 30.52%
FY2023 4.4× (26.37%)
FY2022 6.0× (20.05%)
FY2021 7.6× 24.05%
FY2020 6.1× 32.21%
FY2019 4.6× 8.85%
FY2018 4.2× (13.60%)
FY2017 4.9× 44.91%
FY2016 3.4× 6.22%

Quarterly newest first

Period P/S ratio Change
Jul 2026 5.3× 17.47%
Apr 2026 4.5× (16.92%)
Jan 2026 5.4× (9.35%)
Oct 2025 6.0× 24.54%
43 more quarters

Against its own ten years

Low 2.3× High 8.8×
Ten-year median 5.0×
Current reading's percentile 87

P/S ratio against peers

Company P/S ratio
LH Labcorp Holdings Inc. compare 1.8×
DGX Quest Diagnostics Incorporated compare 2.3×
IQV IQVIA Holdings Inc. compare 2.6×
A Agilent Technologies, Inc. 6.6×
MTD Mettler-Toledo International, Inc. compare 7.9×
ILMN Illumina, Inc. compare 8.8×
WAT Waters Corporation compare 9.2×
IDXX IDEXX Laboratories, Inc. compare 9.7×
NTRA Natera, Inc. compare 20.7×
Diagnostics & Research industry median 4.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on A